StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · COCP·Healthcare

Cocrystal Pharma, Inc. Stock Analysis & AI Score

Cocrystal Pharma, Inc. (COCP) has an ST Score of 33.7 (C-), driven by its Momentum (B+) and held back by its Profitability (F). Analysts rate it Buy.

Market Closed
$1.15
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
34
ST Score
33.7/100C-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

COCP
33.7out of 100
Grade C-

Cocrystal Pharma, Inc. (COCP) has an ST Score of 33.7 (C-), driven by its Momentum (B+) and held back by its Profitability (F). Analysts rate it Buy.

Strongest
MomentumB+
Weakest
ProfitabilityF
All factor grades
  • MomentumB+
  • GrowthB
  • ValuationC-
  • Financial StrengthD-
  • ProfitabilityF
  • Piotroski3/9
Score methodology
Press Releases

Contact

COCP stock: frequently asked questions

What is COCP's ST Score?

Cocrystal Pharma, Inc. (COCP) has an ST Score of 33.7 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is COCP a buy, hold, or sell?

Analysts rate COCP a Buy. Our ST Score grades it C- (33.7/100). The ST Score is a data-driven signal, not a recommendation.

What are COCP's factor grades?

Valuation C-, Profitability F, Financial Strength D-, Momentum B+, Growth B.

What is COCP's valuation grade?

Cocrystal Pharma, Inc. (COCP) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is COCP's growth grade?

Cocrystal Pharma, Inc. (COCP) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is COCP's profitability grade?

Cocrystal Pharma, Inc. (COCP) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is COCP's financial strength grade?

Cocrystal Pharma, Inc. (COCP) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is COCP's Piotroski score?

Cocrystal Pharma, Inc. (COCP) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.